These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9950034)

  • 21. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
    Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
    Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Bcl-x(S) in Xenopus oocytes induces BH3-dependent and caspase-dependent cytochrome c release and apoptosis.
    Braun T; Dar S; Vorobiov D; Lindenboim L; Dascal N; Stein R
    Mol Cancer Res; 2003 Jan; 1(3):186-94. PubMed ID: 12556558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
    Boldt S; Weidle UH; Kolch W
    Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity.
    Primikyri A; Chatziathanasiadou MV; Karali E; Kostaras E; Mantzaris MD; Hatzimichael E; Shin JS; Chi SW; Briasoulis E; Kolettas E; Gerothanassis IP; Tzakos AG
    ACS Chem Biol; 2014 Dec; 9(12):2737-41. PubMed ID: 25211642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.
    Lindenboim L; Borner C; Stein R
    Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of distributions of amino acids in the primary structure of apoptosis regulator Bcl-2 family according to the random mechanism.
    Wu G; Yan S
    J Biochem Mol Biol Biophys; 2002 Dec; 6(6):407-14. PubMed ID: 14972796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl-2-related proteins as drug targets.
    O'Neill JW; Hockenbery DM
    Curr Med Chem; 2003 Aug; 10(16):1553-62. PubMed ID: 12871126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL-2 family members and the mitochondria in apoptosis.
    Gross A; McDonnell JM; Korsmeyer SJ
    Genes Dev; 1999 Aug; 13(15):1899-911. PubMed ID: 10444588
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell death regulation by B-cell lymphoma protein.
    Verma YK; Gangenahalli GU; Singh VK; Gupta P; Chandra R; Sharma RK; Raj HG
    Apoptosis; 2006 Apr; 11(4):459-71. PubMed ID: 16547596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The origin of eukaryotic cells and origination of apoptosis].
    Galitskiĭ VA
    Tsitologiia; 2005; 47(2):103-20. PubMed ID: 16706173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retention factor keeps death at bay.
    Nothwehr SF; Martinou JC
    Nat Cell Biol; 2003 Apr; 5(4):281-3. PubMed ID: 12669077
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of apoptosis by overexpression of Bcl-2 or Bcl-xL promotes survival and mutagenesis after oxidative damage.
    Cherbonnel-Lasserre C; Dosanjh MK
    Biochimie; 1997 Oct; 79(9-10):613-7. PubMed ID: 9466700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the role of conserved cysteine residues in the bcl-2 oncoprotein.
    Maser RS; Antoku K; Scully WJ; Cho RL; Johnson DE
    Biochem Biophys Res Commun; 2000 Oct; 277(1):171-8. PubMed ID: 11027659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BH3-Only proteins-essential initiators of apoptotic cell death.
    Huang DC; Strasser A
    Cell; 2000 Dec; 103(6):839-42. PubMed ID: 11136969
    [No Abstract]   [Full Text] [Related]  

  • 35. Apoptosis: embedded in membranes.
    Bogner C; Leber B; Andrews DW
    Curr Opin Cell Biol; 2010 Dec; 22(6):845-51. PubMed ID: 20801011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis.
    Cherbonnel-Lasserre C; Gauny S; Kronenberg A
    Oncogene; 1996 Oct; 13(7):1489-97. PubMed ID: 8875987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.
    D'Sa-Eipper C; Chinnadurai G
    Oncogene; 1998 Jun; 16(24):3105-14. PubMed ID: 9671389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain.
    Kim JS; Ku B; Woo TG; Oh AY; Jung YS; Soh YM; Yeom JH; Lee K; Park BJ; Oh BH; Ha NC
    Cell Death Dis; 2015 Jul; 6(7):e1804. PubMed ID: 26136077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural insights into the degradation of Mcl-1 induced by BH3 domains.
    Czabotar PE; Lee EF; van Delft MF; Day CL; Smith BJ; Huang DC; Fairlie WD; Hinds MG; Colman PM
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6217-22. PubMed ID: 17389404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
    Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW
    Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.